Ozempic MDL Reaches 3000 Cases Over Side Effects While Users Weigh Benefits Against Risks
Recent developments in the Ozempic multidistrict litigation highlight growing concerns over side effects from the popular weight loss drug. Lawsuit Information Center reports that as of early February...
21 Helmi 2min
GLP-1 Weight Loss Drugs Ozempic and Mounjaro Show 11 to 16 Percent Results Despite Side Effects
Recent Cochrane reviews commissioned by the World Health Organization show that blockbuster weight loss drugs like Ozempic deliver substantial results. According to ScienceDaily reporting on February ...
18 Helmi 2min
GLP-1 Weight Loss Drugs Show Promise: Semaglutide and Tirzepatide Lead Clinical Reviews in 2026
Recent news highlights ongoing developments in weight loss treatments like Ozempic, with fresh insights from clinical reviews and patient experiences. On February 11, 2026, Cochrane reviews commission...
14 Helmi 3min
Ozempic and Wegovy Weight Loss: Benefits, Risks, and Expert Nutrition Guidance
Recent research from the University of Cambridge highlights a key concern with popular weight-loss drugs like Ozempic and Wegovy. These medications sharply reduce appetite, leading to calorie intake d...
11 Helmi 2min
GLP-1 Drugs Like Ozempic Transform Weight Loss Landscape in 2026 With Major Health and Industry Implications
In the past week, weight loss drugs like Ozempic, Wegovy, and Mounjaro have reshaped global conversations on obesity, marking 2026 as a potential turning point. Firstpost reports that these GLP-1 drug...
7 Helmi 2min
Novo Nordisk CagriSema Outperforms Ozempic in Phase III Trial for Type 2 Diabetes and Weight Loss
Novo Nordisk's new drug CagriSema has outperformed Ozempic in a recent Phase III trial for type 2 diabetes patients, according to Clinical Trials Arena. In the REIMAGINE 2 study, CagriSema reduced HbA...
4 Helmi 2min
Oprah Endorses GLP-1 Drugs for Weight Loss as Regulators Issue New Safety Guidance on Semaglutide
Oprah Winfrey has been candid this week about her ongoing use of GLP-1 medications like those containing semaglutide, the active ingredient in Ozempic, for weight management. In recent interviews prom...
31 Tammi 2min
GLP-1 Medications Transform Weight Loss Treatment as Medicaid Coverage Remains Inconsistent Across States
The landscape of weight loss treatment in America is shifting dramatically as glucagon-like peptide-one receptor agonists, or GLP-1s, continue to dominate conversations about obesity management. Accor...
28 Tammi 2min
